Search clinical trials for: N-Rephasin® SAL200

Total 63 results

Intron Biotechnology, Inc.

Completed

A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of N-Rephasin® SAL200 in Healthy Male Volunteers

Healthy Volunteers | Anti-Bacterial Agents | Methicillin-Resistant Staphylococcus Aureus

Korea, Republic of
Intron Biotechnology, Inc.

Terminated

Phase IIa Clinical Study of N-Rephasin® SAL200

Anti-Bacterial Agents | Staphylococcus Aureus Bacteremia

Korea, Republic of
Intron Biotechnology, Inc.

Completed

A Study to Evaluate the Safety, PK, PD, Immunogenicity of N-Rephasin® SAL200 in Healthy Male Volunteers

Healthy Volunteers | Anti-Bacterial Agents | Methicillin-Resistant Staphylococcus Aureus | Methicillin-Sensitive Staphylococcus Aureus Infection

Korea, Republic of
Bionorica SE

Completed

Safety and Efficacy of Canephron® N in the Management of Uncomplicated Urinary Tract Infections (uUTI)

Urinary Tract Infection

Ukraine
Hospital Vall d'Hebron
Bayer Hispania, S.L

Completed

Effect of STW5 (Iberogast ®) and STW5-II (Iberogast N®) on Transit and Tolerance of Intestinal Gas

Functional Dyspepsia | Irritable Bowel Syndrome

Spain
Liaquat University of Medical & Health Sciences

Recruiting

Postoperative Sensitivity Following Placement With Different Restorative Materials In Vital Posterior Teeth (GCP)

Sensitivity, Tooth

Pakistan
Wockhardt

Terminated

Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics

Type I Diabetes

United States, India
Istituto Clinico Humanitas

Completed

Effects of Feet Mechanical Stimulation on Cardiovascular Autonomic Profile and Inflammation in Parkinson's Disease (parkgo-1)

Inflammation | Hypertension | Parkinson's Disease | Autonomic Neuropathy

Italy
Bionorica SE

Completed

Efficacy of CLR Compared to Fosfomycin Trometamol in Acute Lower uUTIs

Urinary Tract Infection

Germany
Guerbet

Completed

Safety and Dialysability of Dotarem® in Dialysed Patients

End-stage Renal Failure

Belgium
Guerbet

Completed

Renal Safety Evaluation After Dotarem®-Enhanced MRI (RESCUE)

Renal Insufficiency

France, Belgium, Spain, Italy
Biocon Limited
Profil Institut für Stoffwechselforschung GmbH

Completed

Comparision of Pharmacokinetic and Pharmacodynamic of Biocon Insulin N and Humulin® N

Healthy Volunteer

Germany
CSL Behring

Completed

Observational Study of Prophylaxis and Treatment of Acute Perioperative Bleeding With Beriplex® P/N (Probe Study)

Coagulation Protein Disorders | Perioperative Care | Blood Loss, Surgical

United Kingdom
Photolitec LLC
National Cancer Institute (NCI); Roswell Park Cancer Institute

Recruiting

Intracavitary Photodynamic Therapy as an Adjuvant to Resection of Glioblastoma or Gliosarcoma Using IV Photobac®

Glioblastoma Multiforme of Brain | Glioma, Sarcomatous

United States
University of Chicago
Guerbet

Completed

Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)

Breast Cancer | Breast Neoplasms | Breast Diseases | Breast Fibroadenoma

United States
CSL Behring

Completed

Study of a Prothrombin Complex Concentrate for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Japanese Subjects

Acute Major Bleeding | Reversal of Coagulopathy

Japan
University of Manitoba

Unknown

Comparison of Cyanoacrylate Adhesives to Sutures in the Palate After Connective Tissue Graft

Wound Closure

Canada
Dipan Shah
Guerbet

Unknown

Efficacy of Dotarem® (Gd-DOTA) Versus Gadovist® (Gd-DO3A-butrol) for Late Gadolinium Enhancement Cardiac Magnetic Resonance

Coronary Artery Disease | Cardiomyopathy
Abbott

Completed

A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect of Creon N and Creon® on Fat Digestion in Subjects ≥ 12 Years of Age With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Hungary, Spain
IBSA Institut Biochimique SA

Completed

Efficacy Study of Intra-articular Hyaluronic Acid in the Knee Osteoarthritis

Osteoarthritis, Knee

Czech Republic, France, Germany, Italy, Slovakia, Switzerland
Randolph Quinn

Completed

Multi-center Study to Investigate the Effects of Citrasate® on Heparin N Requirements During Hemodialysis Treatment

Renal Dialysis

United States
Zambon SpA

Completed

A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus Secretions

Respiratory Tract Diseases | Abnormal Mucus Secretions

China
University of Waterloo

Completed

Comfort Associated With The Use Of Eyelid Cleansing Products Available For The Management Of Demodex Folliculorum (SPANIEL)

Dry Eye

Canada
Hospices Civils de Lyon

Completed

Efficacy of Phosphatidylserine Enriched With n-3 PUFA Supplementation on ADHD in Children With Epilepsy (AGPIn3)

Epilepsy | Child | Attention Deficit Disorder With Hyperactivity | ADHD Inattention or Mixed Type

France
Medical University of Vienna
National Bank of Austria

Completed

n-3 Polyunsaturated Fatty Acids in Obesity (PUFA-ATI)

Morbid Obesity | Adipose Tissue Inflammation

Austria
Atrium Innovations

Withdrawn

Multi-Center Study Evaluating the Efficacy of Wobenzym(R)N in Treating Knee Osteoarthritis

Knee Osteoarthritis

Canada
The Cleveland Clinic
The Surgical Company

Recruiting

Heat Loss in Humans Covered With Full-Body Blankets Connected to Different Warming Devices

Heat Transfer by Clinical Warming Devices

United States
Julphar Gulf Pharmaceutical Industries
Profil Institut für Stoffwechselforschung GmbH

Completed

Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin N and Huminsulin® Basal

Diabetes Mellitus

Germany
Chong Kun Dang Pharmaceutical

Not yet recruiting

MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients (MyMy)

Kidney Transplant
University of Michigan

Completed

Promoting Optimal Healing After Laceration Repair Study (PALS)

Neuralgia, Perineal

United States
The University of Hong Kong
Tung Wah Hospital; Kowloon Hospital, Hong Kong

Completed

Electroacupuncture Combined With Antidepressants for Post-stroke Depression

Depression | Stroke

Hong Kong
The University of Hong Kong
Queen Mary Hospital, Hong Kong; Kowloon Hospital, Hong Kong; Southern Medical...

Completed

A Positron Emission Topographic (PET) Study on Depression Patient With Electroacupuncture

Depression | Major Depressive Disorder

China, Hong Kong
IrsiCaixa

Completed

Impact of Raltegravir Intensification on HIV-1-infected Subjects With Complete Viral Suppression Under Monotherapy With Protease Inhibitors

HIV-1 Infection

Spain
Merck Sharp & Dohme LLC

Active, not recruiting

Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99)

Small Cell Lung Cancer

Poland, Russian Federation, United States, Austria, Canada, Hungary, Israel, Italy, Korea, Republic of, Spain, Switzerland
CSL Behring

Completed

Efficacy and Safety Study of BERIPLEX® P/N (Kcentra) Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant Therapy

Blood Coagulation Disorders | Acute Major Bleeding

United States, Belarus, Bulgaria, Romania, Russian Federation, Ukraine
Washington University School of Medicine

Active, not recruiting

Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: "The Minimalist Trial (MINT)" (MINT)

HPV Related Oropharyngeal Squamous Cell Carcinoma

United States
University of Sao Paulo General Hospital

Completed

Strategy of Transfusion in Trauma Patients - STATA Trial (STATA)

Wounds and Injuries

Brazil
ASIS Corporation

Unknown

ASIS for Enbrel in Plaque Psoriasis (ASISinPP)

Plaque Psoriasis.

United States
University Hospital, Toulouse

Completed

Dopaminergic Loss and Pain in Parkinson's Disease

Pain | Parkinson's Disease

France
CSL Behring

Completed

An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N (Kcentra) Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical Procedure (BE1116_3003)

Reversal of Coagulopathy

United States, Belarus, Bulgaria, Lebanon, Romania, Russian Federation
Carsten Skarke, MD
American Heart Association

Active, not recruiting

Effects of Fish Oil and Red Wine on Oxidative Stress Biomarkers

Healthy

United States
AstraZeneca

Completed

Drug Interaction Study - Assess Pharmacokinetics of Both AZD5672 and Atorvastatin

Healthy Volunteers | Pharmacokinetics

United Kingdom
Lawson Health Research Institute

Recruiting

PET/MR in Post Stroke Cardiac Inflammation Study (PEPSI)

Stroke | Inflammation

Canada
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease

Parkinson's Disease

United States
Drugs for Neglected Diseases

Unknown

BENDITA BEnznidazole New Doses Improved Treatment and Associations (BENDITA)

Chagas Disease

Bolivia
GlaxoSmithKline

Completed

RELOVAIR® Lung Deflation Study

Pulmonary Disease, Chronic Obstructive

United Kingdom
ImmunityBio, Inc.

Terminated

QUILT-3.063: A Study of N-803, haNK and Avelumab in Patients With Merkel Cell Carcinoma That Has Progressed After Checkpoint Therapy

Merkel Cell Carcinoma

United States
GlaxoSmithKline

Completed

A Bioequivalence Study of an Acetylcysteine 2% Oral Solution Versus a Reference Fluimucil 2% Oral Solution

Infections, Respiratory Tract

Germany
Sierra Oncology, Inc.

Terminated

Erlotinib and Momelotinib for the Treatment of Epidermal Growth Factor Receptor (EGFR) Mutated EGFR Tyrosine Kinase Inhibitor (TKI) Naive Metastatic Non-Small Cell Lung Cancer (NSCLC)

EGFR Mutated EGFR TKI Naive Metastatic NSCLC

United States
M.D. Anderson Cancer Center

Recruiting

A Phase II Study of Vibecotamab (XmAb14045) for MRD- Positive AML and MDS After Hypomethylating Agent Failure

AML | MDS

United States

3

Subscribe